GENNEX LABORATORIES
Back to Income Statement
|
GENNEX LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Net Sales | ₹87 Cr | ₹66 Cr | ₹61 Cr | ₹60 Cr | ₹56 Cr |
What is the latest Revenue of GENNEX LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2024 | ₹87 Cr |
| Mar2023 | ₹66 Cr |
| Mar2022 | ₹61 Cr |
| Mar2021 | ₹60 Cr |
| Mar2020 | ₹56 Cr |
How is Revenue of GENNEX LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2024 | ₹87 Cr | 32.18 | |
| Mar2023 | ₹66 Cr | 7.17 | |
| Mar2022 | ₹61 Cr | 2.62 | |
| Mar2021 | ₹60 Cr | 7.25 | |
| Mar2020 | ₹56 Cr | - | |
Compare Revenue of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹367.0 Cr | -8.6% | 18.1% | -23.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | -1.4% | 3.6% | -7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,488.0 Cr | 4.4% | 15.9% | 15.6% | Stock Analytics | |
| CIPLA | ₹121,452.0 Cr | -4.9% | -0.8% | 6.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,057.0 Cr | -0.6% | 1.8% | 15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,220.0 Cr | -4.1% | -3.8% | -4.3% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -8.6% |
18.1% |
-23.4% |
| SENSEX | -1.4% |
3.1% |
3.8% |
You may also like the below Video Courses